SETD2 and acute lymphoblastic leukemia: Finally, alterations in the SETD2 gene were significantly enriched in relapsed pediatric acute lymphoblastic leukemia (ALL) patients, pointing towards a potential role of SETD2 mutations in chemotherapy resistance [23].